Cargando…
Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea
BACKGROUND: Anti-tumor necrosis factor (TNF) agents are increasingly used for rheumatic diseases and inflammatory bowel disease (IBD), but are associated with the development of anti-TNF-induced lupus (ATIL). Nonetheless, few ATIL studies on non-Caucasian IBD patients exist. Here, we investigated th...
Autores principales: | Choi, Su Jin, Ahn, Soo Min, Oh, Ji Seon, Hong, Seokchan, Lee, Chang-Keun, Yoo, Bin, Ye, Byong Duk, Yang, Suk-Kyun, Park, Sang Hyoung, Kim, Yong-Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940731/ https://www.ncbi.nlm.nih.gov/pubmed/33747126 http://dx.doi.org/10.1177/1756284821997794 |
Ejemplares similares
-
Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
por: Ahn, Soo Min, et al.
Publicado: (2022) -
The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
por: Choi, Myeong Geun, et al.
Publicado: (2022) -
Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea
por: Choi, Su Jin, et al.
Publicado: (2022) -
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia
por: Ahn, Soo Min, et al.
Publicado: (2022) -
Long-term renal outcomes of patients with non-proliferative lupus nephritis
por: Kang, Eun-Song, et al.
Publicado: (2023)